ALPS
Price
$0.32
Change
+$0.05 (+18.52%)
Updated
Aug 21 closing price
Capitalization
53.25M
Intraday BUY SELL Signals
VERU
Price
$2.64
Change
+$0.06 (+2.33%)
Updated
Aug 21 closing price
Capitalization
45.01M
95 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ALPS vs VERU

ALPS vs VERU Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ALPS vs. VERU commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALPS is a Hold and VERU is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 23, 2026
Stock price -- (ALPS: $0.32 vs. VERU: $2.64)
Brand notoriety: ALPS and VERU are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALPS: 94% vs. VERU: 45%
Market capitalization -- ALPS: $53.25M vs. VERU: $45.01M
ALPS [@Biotechnology] is valued at $53.25M. VERU’s [@Biotechnology] market capitalization is $45.01M. The market cap for tickers in the [@Biotechnology] industry ranges from $138.91B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALPS’s FA Score shows that 1 FA rating(s) are green whileVERU’s FA Score has 0 green FA rating(s).

  • ALPS’s FA Score: 1 green, 4 red.
  • VERU’s FA Score: 0 green, 5 red.
According to our system of comparison, both ALPS and VERU are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALPS’s TA Score shows that 4 TA indicator(s) are bullish while VERU’s TA Score has 4 bullish TA indicator(s).

  • ALPS’s TA Score: 4 bullish, 4 bearish.
  • VERU’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, ALPS is a better buy in the short-term than VERU.

Price Growth

ALPS (@Biotechnology) experienced а 0.00% price change this week, while VERU (@Biotechnology) price change was -3.30% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.69%. For the same industry, the average monthly price growth was +15.94%, and the average quarterly price growth was +3349.70%.

Reported Earning Dates

VERU is expected to report earnings on Nov 26, 2026.

Industries' Descriptions

@Biotechnology (+3.69% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALPS($53.2M) has a higher market cap than VERU($45M). VERU YTD gains are higher at: 23.364 vs. ALPS (-63.193).
ALPSVERUALPS / VERU
Capitalization53.2M45M118%
EBITDAN/A-28.02M-
Gain YTD-63.19323.364-270%
P/E RatioN/A0.41-
RevenueN/A0-
Total CashN/A30.8M-
Total DebtN/A2.83M-
FUNDAMENTALS RATINGS
VERU: Fundamental Ratings
VERU
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
95
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
47
P/E GROWTH RATING
1..100
81
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALPSVERU
RSI
ODDS (%)
Bullish Trend 3 days ago
44%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
29%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 3 days ago
27%
Bullish Trend 3 days ago
85%
MACD
ODDS (%)
Bearish Trend 3 days ago
22%
Bullish Trend 3 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
30%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
43%
Bullish Trend 3 days ago
79%
Advances
ODDS (%)
Bullish Trend 17 days ago
53%
Bullish Trend 13 days ago
83%
Declines
ODDS (%)
Bearish Trend 4 days ago
75%
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
50%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
62%
Bearish Trend 3 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
ALPS
Daily Signal:
Gain/Loss:
VERU
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LMCLX10.390.09
+0.87%
Miller Income I
BRWIX52.850.44
+0.84%
AMG Boston Common Global Impact I
CIPTX13.380.11
+0.83%
Champlain Strategic Focus Institutional
MXBUX9.700.05
+0.52%
Empower S&P Mid Cap 400® Index L
OTCYX108.460.29
+0.27%
Invesco Discovery Large Cap Y

ALPS and

Correlation & Price change

A.I.dvisor tells us that ALPS and TCRX have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ALPS and TCRX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALPS
1D Price
Change %
ALPS100%
+18.52%
TCRX - ALPS
26%
Poorly correlated
+0.43%
VNDA - ALPS
23%
Poorly correlated
-1.86%
VERU - ALPS
21%
Poorly correlated
+2.33%
SLDB - ALPS
21%
Poorly correlated
+2.20%
ACIU - ALPS
21%
Poorly correlated
+9.85%
More

VERU and

Correlation & Price change

A.I.dvisor indicates that over the last year, VERU has been loosely correlated with INDP. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if VERU jumps, then INDP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VERU
1D Price
Change %
VERU100%
+2.33%
INDP - VERU
47%
Loosely correlated
-6.52%
ABCL - VERU
40%
Loosely correlated
-2.16%
PRAX - VERU
35%
Loosely correlated
+3.12%
RXRX - VERU
35%
Loosely correlated
+4.79%
CRSP - VERU
33%
Loosely correlated
+2.37%
More